INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,326 | +70.1% | 18,626 | +1.5% | 0.00% | – |
| Q2 2023 | $203,039 | +86.0% | 18,358 | +125.8% | 0.00% | – |
| Q1 2023 | $109,186 | +9.2% | 8,130 | +0.6% | 0.00% | – |
| Q4 2022 | $99,987 | -9.9% | 8,083 | +1.1% | 0.00% | – |
| Q3 2022 | $111,000 | +2.8% | 7,997 | +1.8% | 0.00% | – |
| Q2 2022 | $108,000 | -40.7% | 7,855 | -29.9% | 0.00% | – |
| Q1 2022 | $182,000 | +405.6% | 11,200 | +363.4% | 0.00% | – |
| Q3 2021 | $36,000 | +500.0% | 2,417 | +763.2% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 280 | -4.8% | 0.00% | – |
| Q1 2021 | $7,000 | -68.2% | 294 | -66.3% | 0.00% | – |
| Q4 2020 | $22,000 | -100.0% | 872 | -99.9% | 0.00% | -100.0% |
| Q3 2019 | $44,474,000 | -16.6% | 670,200 | 0.0% | 0.02% | -14.3% |
| Q2 2019 | $53,328,000 | +11.3% | 670,200 | +56.4% | 0.03% | +7.7% |
| Q1 2019 | $47,932,000 | +67.9% | 428,500 | +51.3% | 0.03% | +52.9% |
| Q4 2018 | $28,554,000 | -37.6% | 283,300 | +2.6% | 0.02% | -26.1% |
| Q3 2015 | $45,776,000 | -31.3% | 275,991 | 0.0% | 0.02% | -23.3% |
| Q2 2015 | $66,619,000 | -14.4% | 275,991 | 0.0% | 0.03% | -14.3% |
| Q1 2015 | $77,835,000 | -15.4% | 275,991 | -53.2% | 0.04% | -16.7% |
| Q4 2014 | $92,057,000 | +18.3% | 590,107 | +79.5% | 0.04% | +20.0% |
| Q3 2014 | $77,813,000 | +73.0% | 328,757 | +72.9% | 0.04% | +75.0% |
| Q2 2014 | $44,983,000 | -4.0% | 190,100 | +33.8% | 0.02% | -9.1% |
| Q1 2014 | $46,863,000 | – | 142,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |